Current Issue
Commentary
TFAP-2: A Special Regulator with Bidirectional Effect in Human Cancer
J Cancer Immunol, 2021, 3, 1 - 5
Li-Nan Wang, Yi-Liu Yang, Lin-Yong Zhao
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.035]
Commentary
Long Non-coding RNAs in the Pathophysiology of Multiple Myeloma: New Insights on the Role of CRNDE
J Cancer Immunol, 2021, 3, 6 - 12
Simone Zocchi, Antoine David, Michele Goodhardt, David Garrick
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.036]
Commentary
Small-molecule Interferon Inducers for Cancer Immunotherapy Targeting Non-T cell-inflamed Tumors
J Cancer Immunol, 2021, 3, 13 - 17
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.037]
Review Article
SHP2 Inhibition as a Promising Anti-cancer Therapy: Function in Tumor Cell Signaling and Immune Modulation
J Cancer Immunol, 2021, 3, 18 - 29
Jiawan Wang, Lindy Zhang, Christine A. Pratilas, Nicolas J. Llosa
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.038]
Commentary
Expanding the Cancer Neoantigen Peptide Repertoire beyond In silico Tools
J Cancer Immunol, 2021, 3, 30 - 36
Amit Jain, Jackwee Lim
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.039]
Commentary
Lenalidomide Maintenance After Autologous Stem Cell Transplant: The Utility of Real-World Data and Future Areas of Study
J Cancer Immunol, 2021, 3, 37 - 46
Hannah M Cherniawsky, Christopher P Venner, Esther Masih-Khan, Donna Reece
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.040]
Review Article
Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy
J Cancer Immunol, 2021, 3, 47 - 59
Gourab Gupta, Kristina Borglum, Hexin Chen
[DOI No.: https://doi.org/10.33696/cancerimmunol.3.041]
Commentary
Hepatocellular Carcinoma: Diagnosis, Therapy and Molecular Investigations
J Cancer Immunol, 2021, 3, 60 - 65
Veronica Bazzani, Riccardo Pravisani, Umberto Baccarani, Carlo Vascotto